PortalPublikationenImpact of geriatric comorbidity and polypharmacy on cholines...

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.

Standard

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. / Hoffmann, Falk; Bussche van den, Hendrik; Wiese, Birgitt; Schön, Gerhard; Koller, Daniela; Eisele, Marion; Glaeske, Gerd; Scherer, Martin; Kaduszkiewicz, Hanna.

in: BMC PSYCHIATRY, Jahrgang 11, 2011, S. 190.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Hoffmann, F, Bussche van den, H, Wiese, B, Schön, G, Koller, D, Eisele, M, Glaeske, G, Scherer, M & Kaduszkiewicz, H 2011, 'Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.', BMC PSYCHIATRY, Jg. 11, S. 190. https://doi.org/10.1186/1471-244X-11-190

APA

Hoffmann, F., Bussche van den, H., Wiese, B., Schön, G., Koller, D., Eisele, M., Glaeske, G., Scherer, M., & Kaduszkiewicz, H. (2011). Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. BMC PSYCHIATRY, 11, 190. https://doi.org/10.1186/1471-244X-11-190

Vancouver

Hoffmann F, Bussche van den H, Wiese B, Schön G, Koller D, Eisele M et al. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. BMC PSYCHIATRY. 2011;11:190. https://doi.org/10.1186/1471-244X-11-190

Bibtex

@article{5c5e388738a14634bbce020a52b1d677,
title = "Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.",
abstract = "Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs in patients with dementia in Germany.",
keywords = "Comorbidity, Humans, Male, Aged, Female, Aged, 80 and over, Age Factors, Incidence, Retrospective Studies, Germany/epidemiology, Cholinesterase Inhibitors/*therapeutic use, Dementia/*drug therapy/*epidemiology, *Physician's Practice Patterns, *Polypharmacy, Comorbidity, Humans, Male, Aged, Female, Aged, 80 and over, Age Factors, Incidence, Retrospective Studies, Germany/epidemiology, Cholinesterase Inhibitors/*therapeutic use, Dementia/*drug therapy/*epidemiology, *Physician's Practice Patterns, *Polypharmacy",
author = "Falk Hoffmann and {Bussche van den}, Hendrik and Birgitt Wiese and Gerhard Sch{\"o}n and Daniela Koller and Marion Eisele and Gerd Glaeske and Martin Scherer and Hanna Kaduszkiewicz",
year = "2011",
doi = "10.1186/1471-244X-11-190",
language = "English",
volume = "11",
pages = "190",
journal = "BMC PSYCHIATRY",
issn = "1471-244X",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.

AU - Hoffmann, Falk

AU - Bussche van den, Hendrik

AU - Wiese, Birgitt

AU - Schön, Gerhard

AU - Koller, Daniela

AU - Eisele, Marion

AU - Glaeske, Gerd

AU - Scherer, Martin

AU - Kaduszkiewicz, Hanna

PY - 2011

Y1 - 2011

N2 - Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs in patients with dementia in Germany.

AB - Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs in patients with dementia in Germany.

KW - Comorbidity

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Aged, 80 and over

KW - Age Factors

KW - Incidence

KW - Retrospective Studies

KW - Germany/epidemiology

KW - Cholinesterase Inhibitors/therapeutic use

KW - Dementia/drug therapy/epidemiology

KW - Physician's Practice Patterns

KW - Polypharmacy

KW - Comorbidity

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Aged, 80 and over

KW - Age Factors

KW - Incidence

KW - Retrospective Studies

KW - Germany/epidemiology

KW - Cholinesterase Inhibitors/therapeutic use

KW - Dementia/drug therapy/epidemiology

KW - Physician's Practice Patterns

KW - Polypharmacy

U2 - 10.1186/1471-244X-11-190

DO - 10.1186/1471-244X-11-190

M3 - SCORING: Journal article

VL - 11

SP - 190

JO - BMC PSYCHIATRY

JF - BMC PSYCHIATRY

SN - 1471-244X

ER -